Related Experiment Video
Updated: May 3, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Research Progress of NK Cells in Glioblastoma Treatment
Hao Wu1, Qi Liu2, Fenglu Wang1
1Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, People's Republic of China.
Abstract:
NK cells are a type of antitumor immune cell with promising clinical application, following T cells. The activity of NK cells is primarily regulated by their surface receptors and immune microenvironment. In gliomas, the tumor microenvironment exerts a strong immunosuppressive effect, which significantly reduces the clinical efficacy of NK cell immunotherapy. Therefore, this review aims to discuss the latest research on the role of NK cells in glioma immunotherapy, focusing on aspects such as NK cell development, function, and localization. It summarizes information on the compounds, monoclonal antibodies, and cytokine therapies targeting NK cells while emphasizing the current status and trends of gene-modified NK cells in glioma treatment. Additionally, it explores the molecular mechanisms underlying immune escape in glioma cells, providing a theoretical foundation and new perspectives for NK cell-based immunotherapy in gliomas.
Insights
Natural killer (NK) cells show promise for glioma immunotherapy, but the tumor microenvironment
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial antitumor immune cells.
- Glioma's immunosuppressive microenvironment hinders NK cell immunotherapy efficacy.
Purpose of the Study:
- Review the role of NK cells in glioma immunotherapy.
- Discuss NK cell development, function, and localization in gliomas.
- Explore strategies to enhance NK cell-based glioma treatment.
Main Methods:
- Literature review of NK cell research in glioma.
- Analysis of current therapies targeting NK cells.
- Examination of gene-modified NK cell strategies.
Main Results:
- NK cell activity is modulated by receptors and the tumor microenvironment.
- Various therapies (compounds, antibodies, cytokines) are being investigated.
- Gene-modified NK cells represent a promising therapeutic trend.
Conclusions:
- Understanding NK cell dynamics in gliomas is key.
- Targeting NK cells and overcoming immune escape mechanisms are crucial for effective glioma immunotherapy.
- Gene-edited NK cells offer novel therapeutic avenues for gliomas.
More Related Videos
09:18Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018